Danaher focuses on automated urine diagnostics with $338m Iris buy
This article was originally published in Clinica
Executive Summary
Just over a year after purchasing Beckman Coulter for $6.8 billion, Danaher is back on the acquisition trail, having agreed to acquire automated urinalysis specialist Iris International for $19.50 per share, or $338 million in total, including assumed debt.